Immunomodulatory drugs and their application to the management of canine immune‐mediated disease
Authors:
- 26 January 2011
- journal article
- review article
- Published by Wiley in Journal of Small Animal Practice
- Vol. 52 (2) , 70-85
Abstract
This review summarises the current understanding of immune response and T cell subsets in the context of development of autoimmunity in the dog. Mode of action and rational usage in immune‐mediated disease in the dog are discussed for the following drugs: glucocorticoids, azathioprine, cyclophosphamide, ciclosporin, tacrolimus, human intravenous immunoglobulin, vincristine, danazol, leflunomide, mycophenolate mofetil and liposome‐encapsulated clodronate. Disease mechanisms are discussed and published evidence for drug efficacy is scrutinised for five important immune‐mediated diseases: immune‐mediated haemolytic anaemia, immune‐mediated thrombocytopenia, myasthenia gravis, glomerulonephritis and inflammatory bowel disease. Future strategies for more refined manipulation of adverse immune responses are presented.Keywords
This publication has 153 references indexed in Scilit:
- Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006–2008)Journal of the American Veterinary Medical Association, 2010
- Th9 and allergic diseaseImmunology, 2009
- The role of infections in autoimmune diseaseClinical and Experimental Immunology, 2008
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG FcScience, 2008
- Th17: the third member of the effector T cell trilogyCurrent Opinion in Immunology, 2007
- Th1/Th2 balance in canine peripheral blood lymphocytes—A flow cytometric studyVeterinary Immunology and Immunopathology, 2007
- Possible therapeutic vaccines for canine myasthenia gravis: Implications for the human disease and associated fatigueBrain, Behavior, and Immunity, 2007
- Multiple papillomavirus‐associated epidermal hamartomas and squamous cell carcinomasin situin a dog following chronic treatment with prednisone and cyclosporineVeterinary Dermatology, 2005
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- Short-term effect of cyclophosphamide and azathioprine on selected aspects of the canine blastogenic responseVeterinary Immunology and Immunopathology, 1988